Latest Articles

Article Type

Open Access
Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
KATHERINE JUNKINS, MARGARET RODGERS and SHELLEY A. PHELAN

Anticancer Research October 2023, 43 (10) 4333-4339; DOI: https://doi.org/10.21873/anticanres.16628
You have access
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA

Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
Open Access
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression
SUHO PARK, YUNJOO CHO and HYUN-SOO KIM

Anticancer Research October 2023, 43 (10) 4559-4571; DOI: https://doi.org/10.21873/anticanres.16650
Open Access
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI

Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
You have access
Role of Positive Biopsy Core Ratio in Prostate Cancer Patients
HIROSHI KANO, KOUJI IZUMI, RYUNOSUKE NAKAGAWA, REN TORIUMI, SHUHEI AOYAMA, TAIKI KAMIJIMA, TAKAFUMI SHIMADA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research October 2023, 43 (10) 4619-4626; DOI: https://doi.org/10.21873/anticanres.16656
You have access
A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
NORIYOSHI SAWABATA, KOHEI MORITA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKESHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI

Anticancer Research October 2023, 43 (10) 4683-4690; DOI: https://doi.org/10.21873/anticanres.16664
Open Access
Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis
NAEMI GLASER, ANNE PETZOLD, ANJA WESSELY, MATTHIAS D. KAUFMANN, ELIAS A.T. KOCH, HARALD KNORR, CAROLINE VOSKENS, MARKUS V. HEPPT, CAROLA BERKING and MICHAEL ERDMANN

Anticancer Research October 2023, 43 (10) 4525-4532; DOI: https://doi.org/10.21873/anticanres.16646
Open Access
Circulating Tumor Cells and Tumor Progression, Metastasis, and Poor Prognosis in Patients With Neuroblastoma
MASATO KOJIMA and EISO HIYAMA

Anticancer Research October 2023, 43 (10) 4327-4331; DOI: https://doi.org/10.21873/anticanres.16627
Open Access
Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
Anticancer Research October 2023, 43 (10) 4747-4778; DOI: https://doi.org/10.21873/anticanres.16672
Open Access
Retraction
Anticancer Research October 2023, 43 (10) 4780; DOI: https://doi.org/10.21873/anticanres.16674

Main menu

User menu

Search

Latest Articles

Pages